CLDI.WS

Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS

Overview Fund Activity
Delisted

CLDI.WS was delisted on the 17th of October, 2024.

Back to rankings

27 hedge funds and large institutions have $6.17M invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+5
Holders Change %
+22.73%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
3
Closed
2
Calls
$4.88M
Puts
–
Net Calls
+$4.88M
Net Calls Change
+$66K

Top Buyers

1
Nomura Holdings
Nomura Holdings
Japan
$196K
2
6CM
683 Capital Management
New York
$216K
3
SCM
Shaolin Capital Management
Florida
$179K
4
AC
Aristeia Capital
Connecticut
$165K
5
ICM
Ionic Capital Management
New York
$85K

Top Sellers

1
BCM
Beryl Capital Management
California
$0
2
HCM
Highbridge Capital Management
New York
$196K
3
GL
Governors Lane
New York
$67K
4
QGA
Q Global Advisors
Texas
$0
5
WAM
Wolverine Asset Management
Illinois
$30K
Name Holding Trade Value Shares
Change 		Shares
Change %
Walleye Trading
26
Walleye Trading
New York
$7K – – –
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$4K +$4K +11,742 New
AGM
28
Alpine Global Management
New York
$15 +$6 +16,628 +66%
BCM
29
Beryl Capital Management
California
– -$315K -629,999 Closed
QGA
30
Q Global Advisors
Texas
– -$50K -100,000 Closed
1
2